Table 2.
Results of sibutramine therapy in patients split by BMI category
| Treatment duration | BMI 25–29.9 kg/m2 | BMI 30–34.9 kg/m2 | BMI 35–39.9 kg/m2 | BMI > 40 kg/m2 |
|---|---|---|---|---|
| 3 months | ||||
| Body weight loss, kg | −7.13 ± 3.10* | −8.54 ± 3.39 | −9.97 ± 4.2 | −11.94 ± 5.72 |
| Body weight change, % | −8.75 ± 3.79 | −9.32 ± 3.60 | −9.72 ± 3.95 | −10.05 ± 4.5 |
| BMI change, kg/m2 | −2.51 ± 1.09 | −3.05 ± 1.19 | −3.61 ± 1.48 | −4.37 ± 2.06 |
| 6 months | ||||
| Body weight loss, kg | −10.71 ± 4.21 | −13.35 ± 4.87 | −15.97 ± 6.07 | −19.03 ± 7.88 |
| Body weight change, % | −13.07 ± 4.99 | −14.56 ± 5.13 | −15.56 ± 5.67 | −16.02 ± 6.34 |
| BMI change, kg/m2 | −3.75 ± 1.45 | −4.77 ± 1.71 | −5.78 ± 2.13 | −6.96 ± 2.82 |
| 12 months | ||||
| Body weight loss, kg | −12.93 ± 5.05 | −16.84 ± 6.05 | −21.10 ± 7.96 | −26.13 ± 10.99 |
| Body weight change, % | −15.7 ± 5.9 | −18.26 ± 6.29 | −20.46 ±7.38 | −21.90 ± 8.85 |
| BMI change, kg/m2 | −4.5 ±1.71 | −6.0 ± 2.11 | −7.61 ± 2.80 | −9.52 ± 3.89 |
Data are presented as the mean ± SD.